An open-label study of mirtazapine as treatment for combat-related PTSD.
about
Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disordersReview of the use of mirtazapine in the treatment of depression.A review of therapeutic uses of mirtazapine in psychiatric and medical conditions.Posttraumatic stress in school-age children and adolescents: medical providers' role from diagnosis to optimal management.
P2860
An open-label study of mirtazapine as treatment for combat-related PTSD.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
An open-label study of mirtazapine as treatment for combat-related PTSD.
@ast
An open-label study of mirtazapine as treatment for combat-related PTSD.
@en
An open-label study of mirtazapine as treatment for combat-related PTSD.
@nl
type
label
An open-label study of mirtazapine as treatment for combat-related PTSD.
@ast
An open-label study of mirtazapine as treatment for combat-related PTSD.
@en
An open-label study of mirtazapine as treatment for combat-related PTSD.
@nl
prefLabel
An open-label study of mirtazapine as treatment for combat-related PTSD.
@ast
An open-label study of mirtazapine as treatment for combat-related PTSD.
@en
An open-label study of mirtazapine as treatment for combat-related PTSD.
@nl
P2093
P2860
P356
P1476
An open-label study of mirtazapine as treatment for combat-related PTSD.
@en
P2093
Andrew L Gilbert
Christopher P Alderman
John T Condon
P2860
P304
P356
10.1345/APH.1M009
P407
P577
2009-07-07T00:00:00Z